Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 19, 1998

View Archived Issues

MedImmune licenses novel antibacterial technology to Siga

Remune decreases levels of TNF-alpha in HIV-infected patients

Sea cucumber-based agent may increase well-being in HIV/AIDS patients

MGI Pharma: Q4 and FY 1997 highlights

Novel leukotriene antagonist with potential in asthma therapy

Endorex licenses oral hepatitis B vaccine technology

FDA issues positive action letter for SangStat's ciclosporin; European filing announced

Enrollment complete for hepatitis C vaccine phase I trial

OSI Pharmaceuticals: Q1 1998 highlights

Zenapax uveitis and transplant trial data reported

Tazorac launched in Canada

Merck obtains rights to novel drug screening technology

Neurobiological Technologies: Q2 1998 highlights

Icos monoclonal antibody enters phase II for hemorrhagic shock

New gastrointestinal agents reported by Yoshitomi

Shionogi investigates new cephem compounds

Novel imidazoles from Shionogi target lymph nodes

New cell adhesion inhibitors from Shionogi

Lilly claims thrombin inhibitors

New natural or semisynthetic cytotoxic alkaloids from Indena

Hoechst prepares xanthines for cerebrovascular disorders

Development of PNU-95666E moves ahead

Cytokine-inducing profile of imiquimod and two analogues characterized in monkeys

Betaseron slows progression of disability in secondary progressive MS

FDA approves new indication for pilocarpine

Transgenic production program begins for novel HIV therapeutic

Pneumovax does not prevent pneumonia in middle-aged and elderly immunocompetent patients

Another major market introduction for Bayer's statin

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...